These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 22328287

  • 1. Prophylactic adjuvant hepatic arterial infusion chemotherapy reduced hepatic metastases from Stage III colorectal cancer after curative resection.
    Feng WM, Tang CW, Huang SX, Zheng YY, Bao Y, Wang Y, Tao YL.
    Hepatogastroenterology; 2012 Jun; 59(116):1087-90. PubMed ID: 22328287
    [Abstract] [Full Text] [Related]

  • 2. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.
    Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF, Bertino JR, Turnbull AD, Sullivan D, Stockman J, Blumgart LH, Fong Y.
    N Engl J Med; 1999 Dec 30; 341(27):2039-48. PubMed ID: 10615075
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant hepatic arterial infusion chemotherapy after curative resection for Dukes C colorectal cancer: a pilot study.
    Ota M, Shimada H, Masui H, Tanaka K, Yamaguchi S, Ichikawa Y, Togo S, Ike H, Oki S.
    Hepatogastroenterology; 2004 Dec 30; 51(55):124-7. PubMed ID: 15011846
    [Abstract] [Full Text] [Related]

  • 4. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
    Del Freo A, Fiorentini G, Sanguinetti F, Muttini MP, Pennucci C, Mambrini A, Pacetti P, Della Seta R, Lombardi M, Torri T, Cantore M.
    In Vivo; 2006 Dec 30; 20(6A):743-6. PubMed ID: 17203759
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases.
    Goéré D, Deshaies I, de Baere T, Boige V, Malka D, Dumont F, Dromain C, Ducreux M, Elias D.
    Ann Surg; 2010 Apr 30; 251(4):686-91. PubMed ID: 20224373
    [Abstract] [Full Text] [Related]

  • 10. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
    Tsutsumi S, Yamaguchi S, Tsuboi K, Fukasawa T, Tabe Y, Asao T, Kuwano H.
    Hepatogastroenterology; 2008 Apr 30; 55(85):1419-22. PubMed ID: 18795703
    [Abstract] [Full Text] [Related]

  • 11. Intra-arterial 5-fluorouracil and intravenous folinic acid in the treatment of liver metastases from colorectal cancer.
    Howell JD, Warren HW, Anderson JH, Kerr DJ, McArdle CS.
    Eur J Surg; 1999 Jul 30; 165(7):652-8. PubMed ID: 10452259
    [Abstract] [Full Text] [Related]

  • 12. Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies.
    Lorenz M, Staib-Sebler E, Gog C, Proschek D, Jauch KW, Ridwelski K, Hohenberger W, Gassel HJ, Lehmann U, Vestweber KH, Padberg W, Zamzow K, Müller HH.
    Zentralbl Chir; 2003 Feb 30; 128(2):87-94. PubMed ID: 12632273
    [Abstract] [Full Text] [Related]

  • 13. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
    Boige V, Malka D, Elias D, Castaing M, De Baere T, Goere D, Dromain C, Pocard M, Ducreux M.
    Ann Surg Oncol; 2008 Jan 30; 15(1):219-26. PubMed ID: 17896145
    [Abstract] [Full Text] [Related]

  • 14. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H, Ozaki T, Shiina M.
    Cardiovasc Intervent Radiol; 2009 Jul 30; 32(4):679-86. PubMed ID: 19296157
    [Abstract] [Full Text] [Related]

  • 15. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
    Taïeb J, Artru P, Paye F, Louvet C, Perez N, André T, Gayet B, Hebbar M, Goebel FM, Tournigand C, Parc R, de Gramont A.
    J Clin Oncol; 2005 Jan 20; 23(3):502-9. PubMed ID: 15659495
    [Abstract] [Full Text] [Related]

  • 16. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D, Pignon JP, Gelli M, Elias D, Benhaim L, Deschamps F, Caramella C, Boige V, Ducreux M, de Baere T, Malka D.
    BMC Cancer; 2018 Aug 06; 18(1):787. PubMed ID: 30081865
    [Abstract] [Full Text] [Related]

  • 17. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
    Müller H, Nakchbandi V, Chatzisavvidis I, von Voigt C.
    Hepatogastroenterology; 2003 Aug 06; 50(54):1919-26. PubMed ID: 14696433
    [Abstract] [Full Text] [Related]

  • 18. Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.
    Guthoff I, Lotspeich E, Fester C, Wallin I, Schatz M, Ehrsson H, Kornmann M.
    Anticancer Res; 2003 Aug 06; 23(6D):5203-8. PubMed ID: 14981990
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis.
    Kim HR, Min BS, Kim JS, Shin SJ, Ahn JB, Rho JK, Kim NK, Rha SY.
    Oncology; 2011 Aug 06; 81(3-4):175-83. PubMed ID: 22057187
    [Abstract] [Full Text] [Related]

  • 20. Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases.
    Neyns B, Van Nieuwenhove Y, Aerts M, Fontaine C, Vermeij J, Schallier D, Decoster L, De Mey J, Vandenbroucke F, Hoorens A, Delvaux G, De Gréve J.
    Anticancer Res; 2006 Aug 06; 26(1B):611-9. PubMed ID: 16739329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.